find a clinical trial
If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at 201-518-3587, or email us.
351
Clinical Trials
Gastrointestinal (GI) Oncology
Phase III
Enrolling
nct/study# NCT06997497 / MK1084-012
A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084, Cetuximab, and mFOLFOX6 versus mFOLFOX6 With or Without Bevacizumab as First-line Treatment of Participants With KRAS G12C-mutant, Locally Advanced Unresectable or Metastatic Colorectal Cancer (KANDLELIT-012)
Learn More
Gastrointestinal (GI) Oncology
N/A
Enrolling
nct/study# NCT05482516 / ML43975
Evaluating Novel Therapies and ctDNA as a Marker in Curatively-Treated Gastrointestinal Cancers With Microscopic Residual Disease
Learn More
Genito-Urinary
Phase II
Enrolling
nct/study# NCT06632977 / A032102
PREcision DIagnostics in prostate Cancer Treatment (PREDICT)
Learn More
Genito-Urinary
Phase II/III
Enrolling
nct/study# NCT05987241 / A032103
MODERN: AN INTEGRATED PHASE 2/3 AND PHASE 3 TRIAL OF MRD-BASED OPTIMIZATION OF ADJUVANT THERAPY IN UROTHELIAL CANCER
Learn More
Genito-Urinary
Phase III
Enrolling
nct/study# NCT06661720 / A032201
Short TeRm Intensified Pembrolizumab (KEytruda) and Tivozanib for High-Risk Renal Cell Carcinoma – STRIKE
Learn More
Genito-Urinary
N/A
Enrolling
nct/study# N/A / PROSTATECANCERDATABASE/IIT
Active Surveillance for Prostate Cancer-Data and Biological Specimen Collection Protocol
Learn Morewe are here for you
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.